EC Healthcare's (HKG:2138) subsidiary, Jade Master International, completed the sale of its 51% stake in New Medical Centre to AIA Hong Kong Medical Services on Friday, a Monday Hong Kong bourse filing said.
The transaction was first announced in November 2024, with Jade Master agreeing to dispose of the majority stake for HK$437.6 million.
The company also completed the acquisition of a 40% stake in its unit, Hong Kong Medical Advanced Imaging (TST), as part of an internal reorganization within the group.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。